EMA — authorised 9 September 2002
- Marketing authorisation holder: Medtronic BioPharma B.V.
- Status: approved
EMA authorised Inductos on 9 September 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 9 September 2002.
Medtronic BioPharma B.V. holds the EU marketing authorisation.